Trial Profile
Evaluation of baseline Cd4+ T lymphocytes as a predictors of clinical response to rituximab in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 23 Jul 2015 New trial record